The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Vanguard Lepto-ci

. Solution for injection

Zoetis Belgium S.A.VPA10387/085/001

Main Information

Trade NameVanguard Lepto-ci
Active SubstancesLeptospira icterohaemorrhagiae inactivated
Leptospira canicola inactivated
Dosage FormSolution for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/085/001

Group Information

ATC CodeQI07AB01 leptospira
Therapeutic ClassImmunological - Inactivated Vaccine


Licence Issued12/09/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back